+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Search Bar & Filters

Found 5 Actively Recruiting clinical trials

E

Actively Recruiting

Healthy Volunteer

Researchers are investigating new medicines to prevent Human Immunodeficiency Virus Type 1 HIV-1 infection, focusing on women aged 16 to 30 years who are at risk. The study aims to compare the effectiveness and safety of taking MK-8527 once a month against a standard daily pre-exposure prophylaxis PrEP regimen. This phase 3 trial is designed to evaluate if MK-8527 can better prevent HIV-1 infection and how well participants tolerate this medication. Participants will be randomly assigned to one of two groups. One group will take 11 mg of MK-8527 once monthly and a daily placebo matching the standard PrEP medication. The other group will take the daily standard PrEP drugs Emtricitabinetenofovir disoproxil FTCTDF and a monthly placebo matching MK-8527, both for up to approximately two years. After this period, all participants will receive open-label FTCTDF daily for an additional 28 days. During the study, participants will undergo regular monitoring to track new HIV-1 infections, any adverse events, and reasons for discontinuing the study drug due to side effects. The safety and tolerability of MK-8527 will be assessed over the approximately two-year treatment period. The research team will collect data on these outcomes to understand the benefits and risks of MK-8527 as a preventive option for HIV-1 infection.

Age: 16Years - 30YearsFEMALEPhase 3
30 locations
E

Actively Recruiting

Healthy Volunteer

Researchers are evaluating a two-way text-message system called the Maternal Administered Malnutrition Monitoring System MAMMS that provides infant and young child feeding education and supports caregivers in monitoring the nutrition of HIV-exposed children aged 6 to 24 months in Kenya. This study aims to see if MAMMS reduces malnutrition rates, shortens recovery time, lowers hospitalizations and deaths, and improves caregiver knowledge and care-seeking behavior compared to standard care. The trial also assesses the cost and cost-effectiveness of this approach. Caregiver-child pairs are randomly assigned to either the MAMMS intervention or standard care. Those in the MAMMS group receive two MUAC tapes and weekly two-way SMS messages with feeding guidance and prompts to measure and report their childs arm circumference color. If signs of malnutrition are reported, caregivers are asked to visit the clinic for confirmation and treatment. The standard care group gets one-way SMS reminders for clinic visits, and their children receive routine nutritional screening and care. Both groups have follow-up visits at 90 and 180 days. Participants attend enrollment and two follow-up clinic visits where medical history, physical exams, and anthropometric measurements are taken for children and caregivers. Surveys assess caregiver feeding knowledge, trust, and care intentions. The study tracks malnutrition incidence, hospitalizations, deaths, and feeding practices over 180 days. Additional interviews and focus groups evaluate the acceptability and feasibility of the MAMMS system among caregivers and healthcare workers. Participation lasts about six months per pair.

Age: 6Months - 24MonthsAll GendersPhase Not Applicable
2 locations
E

Actively Recruiting

Healthy Volunteer

Researchers are studying how linking digital health data systems and involving community teams can improve the number of antenatal clinic ANC visits for pregnant women. This trial, called C-it DU-it, aims to evaluate whether combining data linkage between community and facility health records with active community involvement can increase ANC contacts compared to enhanced standard care. The study is a cluster-randomized controlled trial conducted in Western Kenya to strengthen health systems and support Kenyas goal of achieving eight ANC visits per pregnancy. The trial compares two groups one using digital data linkage between community health information systems and facility electronic medical records C-it, and the other combining this data linkage with trained community Work Improvement Teams WITs that use the data to identify and solve local problems C-it DU-it. The intervention includes building a digital linkage app, training integrated community teams, and implementing community antenatal contacts. The study is open-label and community-based, with ongoing national efforts to scale up digital health systems. Participants are pregnant women living in the study area, including those up to six weeks postpartum. The study lasts 14 months, during which researchers will measure ANC uptake, socioeconomic impacts, costs to women and households, quality of care, birth attendance, and pregnancy outcomes. They will also assess cost-effectiveness and equity of access. Data collection includes facility and community ANC visits, early attendance, and health economic evaluations to inform potential wider scale-up across counties.

All AgesFEMALEPhase Not Applicable
1 location
S

Actively Recruiting

Healthy Volunteer

Researchers are evaluating three different approaches to testing and managing sexually transmitted infections STIs during pregnancy in Kisumu and Siaya, Kenya. The study aims to compare the effects of these approaches on perinatal outcomes such as pregnancy loss, preterm birth, low birth weight, small size for gestational age, and neonatal death. This randomized controlled trial will involve 3,132 pregnant women receiving antenatal care at selected clinics, with follow-up extending through nine months after delivery. Participants will be randomly assigned to one of three groups standard care involving symptom-based STI management without specific testing for Chlamydia trachomatis CT, Neisseria gonorrhoeae NG, or Trichomonas vaginalis TV universal Xpert4 STI testing regardless of symptoms or Xpert4 testing only for women without STI symptoms. All women diagnosed with STIs or showing symptoms will receive treatment, including expedited partner therapy and tests to confirm cure, following national guidelines. Testing uses a self-collected vaginal swab and is integrated into routine antenatal visits. During the study, participants will undergo regular STI assessments, treatment monitoring, and follow-up visits up to nine months postpartum. Researchers will collect detailed information on demographics, sexual and clinical history, and behavioral factors. Outcomes will be measured at six weeks and nine months postpartum, including STI prevalence, HIV incidence, and quality of care indicators. Participant safety and treatment adherence will be supported with study nurse contact and data monitoring throughout the trial.

All AgesFEMALEPhase Not Applicable
8 locations
S

Actively Recruiting

Healthy Volunteer

Researchers are studying how nutritional supplements made from milk proteins, lactoferrin and lysozyme, may help children aged 6 to 24 months who were hospitalized for diarrhea and have malnutrition. These children are at high risk of repeated diarrhea and poor nutritional recovery despite receiving usual treatments like oral rehydration solutions. The study is a phase 3, double-blind, placebo-controlled randomized trial taking place at seven hospitals in Western Kenya, enrolling 600 participants. Participants will be randomly assigned to receive one of four treatments daily for 16 weeks lactoferrin, lysozyme, a combination of both, or a placebo made of rice powder. Caregivers will mix the assigned supplement with porridge or other complementary foods. After treatment, children will be followed for a total of 24 weeks with clinic visits at weeks 4, 10, 16, and 24, along with bi-weekly home visits by community health workers. During the study, researchers will collect health history information and samples including stool, blood, and possibly urine. They will monitor diarrhea episodes, nutritional recovery, hospitalizations, growth measurements, and markers of intestinal health. Caregivers will report adherence and acceptability of the supplements. The study aims to assess whether these supplements reduce diarrhea recurrence and improve nutrition over six months, while also evaluating safety and cost-effectiveness.

Age: 6Months - 24MonthsAll GendersPhase 3
4 locations